Jamie Heise Selected Research

Anemia

10/2010	Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.
1/2010	Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients.
9/2009	A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jamie Heise Research Topics

Disease

3	Anemia 10/2010 - 09/2009
3	Chronic Hepatitis C 10/2010 - 09/2009
1	Hyperphosphatemia 01/2014
1	Hemolytic Anemia 10/2010
1	Hepatitis C 01/2010
1	Diarrhea 01/2010
1	Hemolysis 09/2009

Drug/Important Bio-Agent (IBA)

3	Ribavirin (Virazole)FDA LinkGeneric 10/2010 - 09/2009
3	taribavirin (viramidine)IBA 10/2010 - 09/2009
2	ProdrugsIBA 10/2010 - 09/2009
1	Phosphates (Orthophosphate)IBA 01/2014
1	InterferonsIBA 01/2010

Therapy/Procedure

2	Drug Tapering 10/2010 - 09/2009
1	Diet Therapy (Therapy, Diet) 01/2014
1	Therapeutics 01/2010